[Long-term therapy with bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia].
Wei
W
HANG
Gang
G
LIU
Jin-ling
JL
ZHANG
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D004564:Electrocoagulation / Q000379:methods; D004724:Endoscopy; D004844:Epistaxis / Q000628:therapy*; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D008875:Middle Aged; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000628:therapy*
D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab